Concepedia

Connor S. Clairmont

CS

Statistics

Publications

10

Citations

850

H-Index

10

Active since

2012

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Howard Hughes Medical Institute

Brigham and Women's Hospital

Connor S. Clairmont is an author at Dana-Farber Cancer Institute specializing in life sciences, dna repair, and molecular biology.

ORCID

Publications per year

2012–2022

10

Publications

10

Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets

Kristen E. Mengwasser, Richard O. Adeyemi, Yumei Leng et al. · Molecular Cell · 2019 · 203 citations · Full text

, , +12

USP1 Is Required for Replication Fork Protection in BRCA1-Deficient Tumors

Kah Suan Lim, Heng Li, Emma A. Roberts et al. · Molecular Cell · 2018 · 181 citations · Full text

, , +14

TRIP13 regulates DNA repair pathway choice through REV7 conformational change

Connor S. Clairmont, Prabha Sarangi, Karthikeyan Ponnienselvan et al. · Nature Cell Biology · 2020 · 161 citations · Full text

, , +11

Biallelic inactivation of REV7 is associated with Fanconi anemia

Dominique Bluteau, Julien Masliah-Planchon, Connor S. Clairmont et al. · Journal of Clinical Investigation · 2016 · 130 citations · Full text

, , +16

p31 <sup>comet</sup> promotes homologous recombination by inactivating REV7 through the TRIP13 ATPase

Prabha Sarangi, Connor S. Clairmont, Lucas D. Galli et al. · Proceedings of the National Academy of Sciences · 2020 · 38 citations · Full text

, , +9

1–5 of 10